Preoperative concomitant boost intensity-modulated radiotherapy with oral capecitabine in locally advanced mid-low rectal cancer: A phase II trial

Radiotherapy and Oncology

Volumn 102, Issue 1, 2012, Pages 4-9

  Li, Jin Luan ^a   Ji, Jia Fu ^b   Cai, Yong ^a   Li, Xiao Fan ^a   Li, Yong Heng ^a   Wu, Hao ^a   Xu, Bo ^a   Dou, Fang Yuan ^b   Li, Zi Yu ^b   Bu, Zhao De ^b   Wu, Ai Wen ^b   Tham, Ivan W K ^c  

^a PEKING UNIVERSITY   (China)

^b PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

^c Singapore Cancer Institute   (Singapore)

Author keywords

Capecitabine; Intensity modulated radiotherapy; Rectal cancer

Indexed keywords

CAPECITABINE;

ADVANCED CANCER; ARTICLE; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; DIARRHEA; DISEASE SEVERITY; DRUG DOSE REDUCTION; FEMALE; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT SAFETY; POSTOPERATIVE COMPLICATION; PREOPERATIVE RADIOTHERAPY; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADIATION DERMATITIS; RECTOVAGINAL FISTULA; RECTUM CANCER; SURVIVAL RATE; TREATMENT RESPONSE;

ADMINISTRATION, ORAL; ADULT; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; COMBINED MODALITY THERAPY; DEOXYCYTIDINE; DISEASE PROGRESSION; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROSPECTIVE STUDIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY, INTENSITY-MODULATED; RECTAL NEOPLASMS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84455199739     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2011.07.030     Document Type: Article

References (34)

1. J.R. Harnsberger, V.M. Vernava III, and W.E. Longo Radical abdominopelvic lymphadenectomy: historic perspective and current role in the surgical management of rectal cancer Dis Colon Rectum 37 1994 73 87
2. E. Kapiteijn, C.A. Marijnen, and A.C. Colenbrander Local recurrence in patients with rectal cancer diagnosed between 1988 and 1992: a population-based study in the west Netherlands Eur J Surg Oncol 24 1998 528 535
3. K. Havenga, W.E. Enker, and J. Norstein Improved survival and local control after total mesorectal excision or D3 lymphadenectomy in the treatment of primary rectal cancer: an international analysis of 1411 patients Eur J Surg Oncol 25 1999 368 374
4. R.J. Heald, B.J. Moran, R.D. Ryall, R. Sexton, and J.K. MacFarlane Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978-1997 Arch Surg 133 1998 894 899
5. E. Kapiteijn, H. Putter, and C.J. van de Velde Cooperative investigators of the Dutch ColoRectal Cancer Group. Impact of the introduction and training of total mesorectal excision on recurrence and survival in rectal cancer in The Netherlands Br J Surg 89 2002 1142 1149
6. K.C. Peeters, C.A. Marijnen, and I.D. Nagtegaal The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma Ann Surg 246 2007 693 701
7. J.F. Bosset, L. Collette, and G. Calais Chemotherapy with preoperative radiotherapy in rectal cancer N Engl J Med 355 2006 1114 1123
8. J.P. Gérard, T. Conroy, and F. Bonnetain Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203 J Clin Oncol 24 2006 4620 4625
9. C. Capirci, V. Valentini, and L. Cionini Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patients Int J Radiat Oncol Biol Phys 72 2008 99 107
10. M.W. Saif, S. Hashmi, D. Zelterman, K. Almhanna, and R. Kim Capecitabine vs continuous infusion 5-FU in neoadjuvant treatment of rectal cancer. A retrospective review Int J Colorectal Dis 23 2008 139 145
11. D.Y. Kim, K.H. Jung, and T.H. Kim Comparison of 5-fluorouracil/leucovorin and capecitabine in preoperative chemoradiotherapy for locally advanced rectal cancer Int J Radiat Oncol Biol Phys 67 2007 378 384
12. V. Velenik, I. Oblak, and F. Anderluh Long-term results from a randomized phase II trial of neoadjuvant combined-modality therapy for locally advanced rectal cancer Radiat Oncol 5 2010 88
13. A. Ballonoff, B. Kavanagh, and M. McCarter Preoperative capecitabine and accelerated intensity-modulated radiotherapy in locally advanced rectal cancer: a phase II trial Am J Clin Oncol 31 2008 264 270
14. S. Roels, W. Duthoy, and K. Haustermans Definition and delineation of the clinical target volume for rectal cancer Int J Radiat Oncol Biol Phys 65 2006 1129 1142
15. M.J. Gallagher, H.D. Brereton, and R.A. Rostock A prospective study of treatment techniques to minimize the volume of pelvic small bowel with reduction of acute and late effects associated with pelvic irradiation Int J Radiat Oncol Biol Phys 12 1986 1565 1573
16. K.L. Baglan, R.C. Frazier, D. Yan, R.R. Huang, A.A. Martinez, and J.M. Robertson The dose-volume relationship of acute small bowel toxicity from concurrent 5-FU-based chemotherapy and radiation therapy for rectal cancer Int J Radiat Oncol Biol Phys 52 2002 176 183
17. O. Dworak, L. Keilholz, and A. Hoffmann Pathological features of rectal cancer after preoperative radiochemotherapy Int J Colorectal Dis 12 1997 19 23
18. C. Rödel, P. Martus, and T. Papadoupolos Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer J Clin Oncol 23 2005 8688 8696
19. R.P. A'Hern Sample size tables for exact single-stage phase II designs Stat Med 20 2001 859 866
20. T.R. Fleming One-sample multiple testing procedure for phase II clinical trials Biometrics 38 1982 143 151
21. V. Valentini, R. Beets-Tan, and J.M. Borras Evidence and research in rectal cancer Radiother Oncol 87 2008 449 474
22. G.M. Freedman, N.J. Meropol, and E.R. Sigurdson Phase I trial of preoperative hypofractionated intensity-modulated radiotherapy with incorporated boost and oral capecitabine in locally advanced rectal cancer Int J Radiat Oncol Biol Phys 67 2007 1389 1393
23. C. Aschele, C. Pinto, and S. Cordio Preoperative fluorouracil (FU)-based chemoradiation with, without weekly oxaliplatin in locally advanced rectal cancer: pathologic response analysis of the Studio Terapia Adiuvante Retto (STAR)-01 randomized phase III trial J Clin Oncol 27 2009 170s [suppl; abstr CRA4008]
24. C. Rödel, G.G. Grabenbauer, T. Papadopoulos, W. Hohenberger, H.J. Schmoll, and R. Sauer Phase I/II trial of capecitabine, oxaliplatin, and radiation for rectal cancer J Clin Oncol 21 2003 3098 3104
25. J.P. Gérard, D. Azria, and S. Gourgou-Bourgade Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: results of the phase III trial ACCORD 12/0405-Prodige 2 J Clin Oncol 28 2010 1638 1644
26. Y.J. Chua, Y. Barbachano, and D. Cunningham Neoadjuvant capecitabine and oxaliplatin before chemoradiotherapy and total mesorectal excision in MRI-defined poor-risk rectal cancer: a phase 2 trial Lancet Oncol 11 2010 241 248
27. J.F. Fowler The linear-quadratic formula and progress in fractionated radiotherapy Br J Radiol 62 1989 679 694
28. B. Jones, and R.G. Dale Mathematical models of tumour and normal tissue response Acta Oncol 38 1999 883 893
29. P.A. Coucke, M. Notter, and B. Stamm Preoperative hyper-fractionated accelerated radiotherapy (HART) in locally advanced rectal cancer (LARC) immediately followed by surgery. A prospective phase II trial Radiother Oncol 79 2006 52 58
30. K. Bujko, M.P. Nowacki, and A. Nasierowska-Guttmejer Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapy Radiother Oncol 72 2004 15 24
31. J.P. Gerard The Estro Regaud Lecture. Radiotherapy in the conservative treatment of rectal cancer. Evidence-based medicine and opinion Radiother Oncol 74 2005 227 233
32. A. De Paoli, S. Chiara, and G. Luppi Capecitabine in combination with preoperative radiation therapy in locally advanced, resectable, rectal cancer: a multicentric phase II study Ann Oncol 17 2006 246 251
33. R. Sauer, H. Becker, and W. Hohenberger Preoperative versus postoperative chemoradiotherapy for rectal cancer N Engl J Med 351 2004 1731 1740
34. A. Debucquoy, S. Roels, and L. Goethals Double blind randomized phase II study with radiation + 5-fluorouracil ± celecoxib for resectable rectal cancer Radiother Oncol 93 2009 273 278